We collected information about Genocea Biosciences Inc Hours for you. Follow the liks to find out everything about Genocea Biosciences Inc Hours.
Genocea | Making better cancer immunotherapies for patients. Making better cancer immunotherapies for patients, starting with better target discovery. That’s why we say #TargetsMatter. ATLAS™ – a unique and proprietary discovery platform – designed to identify the right targets (antigens) of anti-tumor responses in any patient.
https://www.nasdaq.com/market-activity/stocks/gnca/after-hours
Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET).
https://www.barrons.com/market-data/stocks/gnca
December 1, 2021 EST. After Hours Vol. 15. Price at close. $ 1.3800. -0.0200. -1.43%. Nov 26, 2021 1:00 p.m. EST. About Genocea Biosciences Inc. Genocea Biosciences, Inc. engages in the ...
https://www.marketwatch.com/investing/stock/GNCA/company-profile
100 Acorn Park Drive. 5th floor. Cambridge, Massachusetts 02140. Phone 1 617 876-8191. Industry Biotechnology. Sector Health Care/Life Sciences. …
https://ir.genocea.com/news-releases/news-release-details/genocea-host-third-quarter-2021-corporate-update-conference-call
CAMBRIDGE, Mass., Oct. 21, 2021 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing next-generation cancer immunotherapies, will host its third quarter 2021 corporate update conference call and live audio webcast on Thursday, October 28 th at 8:30 a.m. E.T. Interested participants may access the …
https://www.marketwatch.com/investing/stock/gnca
Genocea Biosciences stock price target cut to $4 from $18 at Stifel Nicolaus. Nov. 10, 2020 at 7:13 a.m. ET by Tomi Kilgore.
https://www.genocea.com/about/
Diantha joined Genocea in March 2019, bringing broad life science financial leadership experience to the company. Most recently, Diantha served as Vice President, Controller and Chief Accounting Officer at Bioverativ, Inc. Prior to Bioverativ, she served as U.S. and Global Commercial Controller at Biogen and held a number of positions as an Executive Director at Merck and Co.
https://newsheater.com/2021/10/29/heres-how-your-trade-genocea-biosciences-inc-gnca-aggressively-right-now/
Genocea Biosciences Inc. (NASDAQ:GNCA) went up by 7.78% from its latest closing price compared to the recent 1-year high of $4.05. The company’s stock price has collected 3.45% of gains in the last five trading sessions. Press Release reported 16 hours ago that Genocea Provides Third Quarter 2021 Corporate Update.
https://ir.genocea.com/news-releases/news-release-details/genoceas-gen-009-vaccine-demonstrates-best-class-immune
A webcast replay of the conference call will be available on the Genocea website beginning approximately two hours after the event and will be archived for 90 days. About Genocea Biosciences, Inc. Genocea is a biopharmaceutical company developing personalized cancer immunotherapies.
Searching for Genocea Biosciences Inc Hours?
You can just click the links above. The info is collected for you.
